PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 6 months ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics lance un processus de recherche de repreneurs dans le cadre de son redressement judiciaire. Appel d'offres ouvert jusqu'au 11 avril 2025 Appel D'offres Redressement Judiciaire Repreneurs Procédure PHAXIAM Therapeutics
BRIEF published on 03/06/2025 at 18:01, 1 year 7 months ago PHAXIAM Therapeutics entre en redressement judiciaire et retarde ses résultats financiers Retard Des Résultats Financiers Administrateur Judiciaire Suspension Des Échanges Mise Sous Séquestre De PHAXIAM Défis Biotechnologiques
BRIEF published on 03/06/2025 at 18:01, 1 year 7 months ago PHAXIAM Therapeutics Enters Receivership and Delays Financial Results Trading Suspension Financial Results Delay PHAXIAM Receivership Biotech Challenges Court-appointed Administrator
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 7 months ago Informations privilégiées / Autres communiqués PHAXIAM annonce l'ouverture d'une procédure de redressement judiciaire et le report de la publication de ses résultats financiers 2024. La Société se place sous la protection du Tribunal de commerce de Lyon Résultats Financiers Tribunal De Commerce Redressement Judiciaire PHAXIAM Procédure
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 7 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces the opening of a receivership procedure and postponement of its 2024 financial results publication. The company continues operations under observation period Financial Results Biopharmaceutical Company PHAXIAM Therapeutics Receivership Procedure Phage-based Treatments
BRIEF published on 03/06/2025 at 11:45, 1 year 7 months ago Suspension de la Cotation de PHAXIAM Therapeutics Euronext Paris Biopharmaceutique Suspension Cotation PHAXIAM Therapeutics Infections Résistantes
BRIEF published on 03/06/2025 at 11:45, 1 year 7 months ago Suspension of the Listing of PHAXIAM Therapeutics Euronext Paris Biopharmaceutical PHAXIAM Therapeutics Suspension Of Quotation Resistant Infections
PRESS RELEASE published on 03/06/2025 at 11:40, 1 year 7 months ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics suspend sa cotation sur Euronext Paris en attendant un prochain communiqué. La société développe des traitements innovants contre les infections bactériennes Cotation Suspension Traitements Innovants PHAXIAM Therapeutics Infections Bactériennes
BRIEF published on 12/30/2024 at 17:50, 1 year 9 months ago PHAXIAM Therapeutics: Promising results from the PhagoDAIR pilot study Infection Control PHAXIAM Therapeutics Phase II GLORIA PhagoDAIR Study Anti-S. Aureus Phages
BRIEF published on 12/30/2024 at 17:50, 1 year 9 months ago PHAXIAM Therapeutics : résultats prometteurs de l’étude pilote PhagoDAIR PHAXIAM Therapeutics Étude PhagoDAIR Phages Anti-S. Aureus Phase II GLORIA Contrôle De L'infection
Published on 10/07/2026 at 11:00, 1 hour 6 minutes ago GMV Minerals Announces Assays from 2026 Diamond Drill Program including: 12.64 gpt Gold over 4.88 m in MHC26-14
Published on 10/07/2026 at 08:00, 4 hours 6 minutes ago VEON and Amdocs Enter 10-Year Strategic Agreement to Advance Digital Services powered by Amdocs' AI technology
Published on 10/07/2026 at 01:45, 10 hours 21 minutes ago Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:30, 10 hours 36 minutes ago ECC Ventures 4 Corp. Announces Resumption of Trading
Published on 10/07/2026 at 01:05, 11 hours 1 minute ago Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/07/2026 at 11:41, 24 minutes ago VERBUND AG: Stefan Waldner appointed Chief Financial Officer
Published on 10/07/2026 at 11:36, 29 minutes ago Branicks Group AG: Maturity Extension of the EUR 400 Million Bond Implemented
Published on 10/07/2026 at 10:00, 2 hours 6 minutes ago Élections de deux nouveaux membres au Conseil d’administration de Vaudoise Asset Management SA
Published on 10/07/2026 at 10:30, 1 hour 36 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 10/07/2026 at 10:17, 1 hour 48 minutes ago Déclaration d'actions et de droits de vote au 30.09.2026
Published on 10/07/2026 at 08:15, 3 hours 51 minutes ago EURAZEO TO ACQUIRE MIYA WATER, A GLOBAL SPECIALIST IN EFFICIENT WATER MANAGEMENT SOLUTIONS
Published on 10/07/2026 at 08:15, 3 hours 51 minutes ago EURAZEO ACQUIERT MIYA WATER, SPECIALISTE MONDIAL DES SOLUTIONS D’EFFICACITE DES RESEAUX D’EAU
Published on 10/07/2026 at 08:00, 4 hours 6 minutes ago Neoen lance la construction du parc éolien Goyder North en South Australia
